New naloxone nasal spray at least doubles the dose
The Food and Drug Administration today a naloxone hydrochloride nasal spray to treat opioid overdoses that delivers 8 milligrams of naloxone, up from 2 mg or 4 mg in previously approved products.
鈥淎ddressing the opioid crisis is a top priority for the FDA, and we will continue our efforts to increase access to naloxone and place this important medicine in the hands of those who need it most,鈥 said Patrizia Cavazzoni, M.D., director of FDA鈥檚 Center for Drug Evaluation and Research.
Related News Articles
Headline
The Trump administration yesterday released executive orders on reducing anti-competitive regulatory barriers and repealing certain regulations deemed unlawful鈥
Headline
The Department of Health and Human Services Feb. 28 announced that it is rescinding its Nixon-era policy on inviting public participation when making rules and鈥
Headline
The Food and Drug Administration yesterday released recommendations for streamlining the approval process for medical devices that use artificial intelligence鈥
Perspective
All of America鈥檚 hospitals and health systems are cornerstones of their communities. They not only deliver around-the-clock care and essential services to鈥
Headline
An EY report prepared for the AHA shows that tax-exempt hospitals and health systems delivered $10 in benefits to their communities for every dollar鈥檚 worth of鈥
Headline
The U.S. Department of Health and Human Services will not appeal its loss in 黑料正能量 Association v. Becerra. The AHA, joined by the Texas Hospital鈥